Arch Therapeutics Inc
OTC:ARTH
Balance Sheet
Balance Sheet Decomposition
Arch Therapeutics Inc
Arch Therapeutics Inc
Balance Sheet
Arch Therapeutics Inc
| Sep-2011 | Sep-2012 | Sep-2013 | Sep-2014 | Sep-2015 | Sep-2016 | Sep-2017 | Sep-2018 | Sep-2019 | Sep-2020 | Sep-2021 | Sep-2022 | Sep-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
1
|
1
|
4
|
5
|
6
|
5
|
2
|
1
|
2
|
1
|
0
|
|
| Cash |
0
|
0
|
1
|
1
|
4
|
5
|
6
|
5
|
2
|
1
|
2
|
1
|
0
|
|
| Total Receivables |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
2
|
1
|
4
|
5
|
6
|
5
|
3
|
2
|
4
|
3
|
2
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
N/A
|
2
+7 850%
|
1
-45%
|
4
+355%
|
5
+28%
|
6
+18%
|
5
-21%
|
3
-40%
|
2
-26%
|
4
+71%
|
3
-29%
|
2
-25%
|
|
| Liabilities | ||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
2
|
|
| Accrued Liabilities |
0
|
1
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
2
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
6
|
|
| Other Current Liabilities |
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
|
| Total Current Liabilities |
0
|
3
|
0
|
3
|
1
|
2
|
0
|
0
|
1
|
1
|
2
|
3
|
9
|
|
| Long-Term Debt |
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
2
|
3
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
4
|
0
|
0
|
3
|
3
|
3
|
2
|
1
|
1
|
0
|
|
| Total Liabilities |
0
N/A
|
3
N/A
|
1
-50%
|
8
+455%
|
2
-68%
|
2
-20%
|
4
+95%
|
3
-10%
|
4
+7%
|
4
-2%
|
5
+29%
|
7
+45%
|
9
+39%
|
|
| Equity | ||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
3
|
5
|
13
|
16
|
22
|
30
|
34
|
39
|
44
|
50
|
55
|
62
|
|
| Additional Paid In Capital |
0
|
0
|
5
|
6
|
17
|
25
|
32
|
36
|
38
|
42
|
49
|
51
|
55
|
|
| Total Equity |
0
N/A
|
3
N/A
|
0
N/A
|
7
N/A
|
2
N/A
|
3
+105%
|
2
-29%
|
1
-39%
|
1
N/A
|
2
-85%
|
1
+31%
|
4
-307%
|
8
-79%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
N/A
|
2
+7 850%
|
1
-45%
|
4
+355%
|
5
+28%
|
6
+18%
|
5
-21%
|
3
-40%
|
2
-26%
|
4
+71%
|
3
-29%
|
2
-25%
|
|
| Shares Outstanding | ||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
5
|
|